The virus already has cost the region hundreds of millions of dollars, tens of thousands of jobs and more than 1,800 lives. Those losses are all but certain to grow as the calendar turns to 2021, amid an international effort to roll out an effective vaccine.
The violence, which many Hoosiers watched live on TV news, served as another body blow to downtown, which already was reeling from the loss of conventions and the shutdown of many offices during the pandemic.
The blockbuster announcement secures Elanco’s future in central Indiana and provide a long-sought reuse for at least part of the stamping plant site, which has been vacant for almost a decade.
The U.S. Food and Drug Administration cleared the experimental drug for people 12 and older with mild or moderate symptoms not requiring hospitalization.
The biggest chunk—$10.5 million—has been dedicated to 15 community and multi-service centers that offer a range of services, such as health care, child care, counseling, job training and youth development, as well as programs for seniors.
For a highly touted drug meant to keep throngs of people out of hospitals during a pandemic, Eli Lilly and Co.’s wonder treatment bamlanivimab sure has been slow to catch on.
The experimental drug, donanemab, could be a huge breakthrough for Lilly, which has spent billions of dollars over 30 years researching treatments for Alzheimer’s disease, only to see them fall short in clinical trials.
So far this month, drugmakers have hiked prices on 636 drugs, according to research by GoodRx, which tracks prescription drug prices and offer a mobile app to help consumers find the lowest prices on hundreds of drugs.
The bill would shield businesses and individuals from coronavirus civil liability lawsuits unless there was gross negligence or willful or wanton misconduct that could be proven with “clear and convincing evidence.”
Merus N.V. specializes is so-called CD3 engaging T-cell therapies, a growing area of cancer research, based on immunotherapy, or using the immune system’s T cells to find and shrink tumors
Lilly’s announcement Thursday comes as the disease continues to hit hard in U.S. nursing homes, accounting for more than 100,000 deaths of residents and staff over the course of the pandemic.
The maker of animal feeds and vaccines also is closing research and development sites in Germany and New Zealand, and making smaller cuts elsewhere. Altogether, Elanco is chopping 350 jobs in 23 countries.
GlaxoSmithKline and partner Vir Biotechnology Inc. have teamed up with Indianapolis-based Eli Lilly and Co. to test a combination of their COVID-19 antibody treatments to see whether they can better combat the virus and its variants together.
The new majority owner says it plans to retain the Stutz property’s historic character but isn’t yet revealing details about its plans for the 110-year-old downtown complex.
